MERTK and prostate carcinoma: Phosphorylated MerTK (pMerTK) increases 1 h following apoptotic LNCaP cell addition in M2 THP-1 macrophages (Fig. 4A-B), indicating a role of MerTK in prostate cancer cell efferocytosis specifically.